Financhill
Buy
57

MMSI Quote, Financials, Valuation and Earnings

Last price:
$99.00
Seasonality move :
10.04%
Day range:
$97.90 - $99.14
52-week range:
$70.70 - $111.45
Dividend yield:
0%
P/E ratio:
48.74x
P/S ratio:
4.33x
P/B ratio:
4.22x
Volume:
380.3K
Avg. volume:
608.3K
1-year change:
37.55%
Market cap:
$5.8B
Revenue:
$1.4B
EPS (TTM):
$2.03

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MMSI
Merit Medical Systems
$351.5M $0.83 8.97% 56.02% $118.20
ARAY
Accuray
$110.4M -$0.04 0.39% -8.33% $6.13
BDX
Becton Dickinson &
$5.5B $3.56 6.03% 77.19% $276.77
BSX
Boston Scientific
$4.8B $0.71 18.49% 103.33% $115.62
ICUI
ICU Medical
$603.7M $1.57 1.32% 316.67% $190.00
MASI
Masimo
$593.3M $1.43 -25.37% 192.38% $193.76
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MMSI
Merit Medical Systems
$98.94 $118.20 $5.8B 48.74x $0.00 0% 4.33x
ARAY
Accuray
$1.83 $6.13 $188.2M -- $0.00 0% 0.41x
BDX
Becton Dickinson &
$225.98 $276.77 $64.9B 37.54x $1.04 1.76% 3.18x
BSX
Boston Scientific
$97.16 $115.62 $143.4B 77.73x $0.00 0% 8.62x
ICUI
ICU Medical
$143.22 $190.00 $3.5B -- $0.00 0% 1.47x
MASI
Masimo
$168.21 $193.76 $9.1B 116.80x $0.00 0% 4.35x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MMSI
Merit Medical Systems
34.59% 1.540 12.84% 2.71x
ARAY
Accuray
78.56% 2.409 86.22% 0.78x
BDX
Becton Dickinson &
42.67% 0.476 28.8% 0.44x
BSX
Boston Scientific
32.79% 0.683 8.05% 0.46x
ICUI
ICU Medical
44.61% 1.886 41.61% 0.92x
MASI
Masimo
42.11% 1.378 8.64% 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MMSI
Merit Medical Systems
$173M $36.7M 5.83% 9.36% 11.58% $64.5M
ARAY
Accuray
$41.9M $4.7M -2% -9.63% 5.26% $231K
BDX
Becton Dickinson &
$2.2B $546M 3.92% 6.75% 8.92% $588M
BSX
Boston Scientific
$3.1B $790M 5.97% 8.96% 14.58% $1.2B
ICUI
ICU Medical
$227.3M $46.1M -3.22% -5.75% 5.46% $13.6M
MASI
Masimo
$244.7M -$54.6M -14.23% -23.05% -58.55% $47.5M

Merit Medical Systems vs. Competitors

  • Which has Higher Returns MMSI or ARAY?

    Accuray has a net margin of 7.87% compared to Merit Medical Systems's net margin of 2.18%. Merit Medical Systems's return on equity of 9.36% beat Accuray's return on equity of -9.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.71% $0.46 $2.1B
    ARAY
    Accuray
    36.06% $0.02 $223.4M
  • What do Analysts Say About MMSI or ARAY?

    Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Accuray has an analysts' consensus of $6.13 which suggests that it could grow by 234.7%. Given that Accuray has higher upside potential than Merit Medical Systems, analysts believe Accuray is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    ARAY
    Accuray
    3 0 0
  • Is MMSI or ARAY More Risky?

    Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Accuray has a beta of 1.460, suggesting its more volatile than the S&P 500 by 46.041%.

  • Which is a Better Dividend Stock MMSI or ARAY?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Accuray pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or ARAY?

    Merit Medical Systems quarterly revenues are $355.2M, which are larger than Accuray quarterly revenues of $116.2M. Merit Medical Systems's net income of $27.9M is higher than Accuray's net income of $2.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Accuray's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 0.41x for Accuray. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.33x 48.74x $355.2M $27.9M
    ARAY
    Accuray
    0.41x -- $116.2M $2.5M
  • Which has Higher Returns MMSI or BDX?

    Becton Dickinson & has a net margin of 7.87% compared to Merit Medical Systems's net margin of 5.86%. Merit Medical Systems's return on equity of 9.36% beat Becton Dickinson &'s return on equity of 6.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.71% $0.46 $2.1B
    BDX
    Becton Dickinson &
    43.25% $1.04 $44B
  • What do Analysts Say About MMSI or BDX?

    Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Becton Dickinson & has an analysts' consensus of $276.77 which suggests that it could grow by 22.48%. Given that Becton Dickinson & has higher upside potential than Merit Medical Systems, analysts believe Becton Dickinson & is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    BDX
    Becton Dickinson &
    8 3 0
  • Is MMSI or BDX More Risky?

    Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.355, suggesting its less volatile than the S&P 500 by 64.526%.

  • Which is a Better Dividend Stock MMSI or BDX?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 1.76% to investors and pays a quarterly dividend of $1.04 per share. Merit Medical Systems pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MMSI or BDX?

    Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Becton Dickinson & quarterly revenues of $5.2B. Merit Medical Systems's net income of $27.9M is lower than Becton Dickinson &'s net income of $303M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Becton Dickinson &'s PE ratio is 37.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 3.18x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.33x 48.74x $355.2M $27.9M
    BDX
    Becton Dickinson &
    3.18x 37.54x $5.2B $303M
  • Which has Higher Returns MMSI or BSX?

    Boston Scientific has a net margin of 7.87% compared to Merit Medical Systems's net margin of 12.41%. Merit Medical Systems's return on equity of 9.36% beat Boston Scientific's return on equity of 8.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.71% $0.46 $2.1B
    BSX
    Boston Scientific
    67.86% $0.38 $32.6B
  • What do Analysts Say About MMSI or BSX?

    Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Boston Scientific has an analysts' consensus of $115.62 which suggests that it could grow by 19%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    BSX
    Boston Scientific
    23 4 0
  • Is MMSI or BSX More Risky?

    Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.845%.

  • Which is a Better Dividend Stock MMSI or BSX?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or BSX?

    Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Boston Scientific quarterly revenues of $4.6B. Merit Medical Systems's net income of $27.9M is lower than Boston Scientific's net income of $566M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Boston Scientific's PE ratio is 77.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 8.62x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.33x 48.74x $355.2M $27.9M
    BSX
    Boston Scientific
    8.62x 77.73x $4.6B $566M
  • Which has Higher Returns MMSI or ICUI?

    ICU Medical has a net margin of 7.87% compared to Merit Medical Systems's net margin of -3.78%. Merit Medical Systems's return on equity of 9.36% beat ICU Medical's return on equity of -5.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.71% $0.46 $2.1B
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
  • What do Analysts Say About MMSI or ICUI?

    Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand ICU Medical has an analysts' consensus of $190.00 which suggests that it could grow by 32.66%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    ICUI
    ICU Medical
    3 1 0
  • Is MMSI or ICUI More Risky?

    Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.733, suggesting its less volatile than the S&P 500 by 26.693%.

  • Which is a Better Dividend Stock MMSI or ICUI?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or ICUI?

    Merit Medical Systems quarterly revenues are $355.2M, which are smaller than ICU Medical quarterly revenues of $629.8M. Merit Medical Systems's net income of $27.9M is higher than ICU Medical's net income of -$23.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 1.47x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.33x 48.74x $355.2M $27.9M
    ICUI
    ICU Medical
    1.47x -- $629.8M -$23.8M
  • Which has Higher Returns MMSI or MASI?

    Masimo has a net margin of 7.87% compared to Merit Medical Systems's net margin of -58.2%. Merit Medical Systems's return on equity of 9.36% beat Masimo's return on equity of -23.05%.

    Company Gross Margin Earnings Per Share Invested Capital
    MMSI
    Merit Medical Systems
    48.71% $0.46 $2.1B
    MASI
    Masimo
    40.74% -$6.52 $1.8B
  • What do Analysts Say About MMSI or MASI?

    Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Masimo has an analysts' consensus of $193.76 which suggests that it could grow by 15.19%. Given that Merit Medical Systems has higher upside potential than Masimo, analysts believe Merit Medical Systems is more attractive than Masimo.

    Company Buy Ratings Hold Ratings Sell Ratings
    MMSI
    Merit Medical Systems
    5 1 0
    MASI
    Masimo
    4 3 0
  • Is MMSI or MASI More Risky?

    Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Masimo has a beta of 1.035, suggesting its more volatile than the S&P 500 by 3.537%.

  • Which is a Better Dividend Stock MMSI or MASI?

    Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MMSI or MASI?

    Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Masimo quarterly revenues of $600.7M. Merit Medical Systems's net income of $27.9M is higher than Masimo's net income of -$349.6M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 4.35x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MMSI
    Merit Medical Systems
    4.33x 48.74x $355.2M $27.9M
    MASI
    Masimo
    4.35x 116.80x $600.7M -$349.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock